Gamma knife surgery for brain metastases: indications for and limitations of a local treatment protocol

Acta Neurochir (Wien). 2005 Jul;147(7):721-6; discussion 726. doi: 10.1007/s00701-005-0540-4. Epub 2005 May 20.

Abstract

Objective: The purpose of this retrospective study was to evaluate results of a local treatment protocol using gamma knife surgery (GKS) for brain metastases without upfront whole brain radiation therapy (WBRT).

Methods: Results for 521 consecutive patients satisfying the following 3 criteria were analysed: 1) a maximum of 3 tumours with a diameter of 25 mm or more; 2) no prior WBRT; 3) no surgically in accessible large (>30 mm) tumours. Large tumours were surgically removed and all smaller lesions were treated by GKS without up front WBRT. New lesions, detected with follow-up MRI, were appropriately treated with repeat GKS. Overall survival (OS), neurological survival (NS), qualitative survival (QS) and new lesion-free survival (NLFS) curves were calculated and the prognostic values of covariates were obtained. OS and NS were compared according to tumour number.

Results: In total, 1023 separate sessions were required to treat 4562 lesions. The primary organs were lung in 369 patients, gastro-intestinal tract in 70, breast in 33, urinary tract in 24, and others/unknown in 25. The median OS period was 9.0 months. On multivariate analysis, the significant prognostic factors for OS were found to be extracranial disease (risk factor: active), Karnofsky performance status (KPS) score (<70) and gender (male). NS and QS at one year were 85.6% and 73.0%, respectively. The only significantly poor prognostic factor for NS was carcinomatous meningitis. NLFS at 6 months was 68.9%. For both OS and NS, the differences between a few (</=3) and many (4-10) brain lesions were not significant (OS: p=0.3128, NS: p=0.5509). Patients with numerous (>10) tumours had a significantly poorer prognosis than those with </=10.

Conclusion: Our protocol, aggressively applying GKS, provides excellent results in selected patients with </=10 brain lesions and no carcinomatous meningitis.

MeSH terms

  • Aged
  • Brain Damage, Chronic / diagnosis
  • Brain Damage, Chronic / mortality
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / mortality
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / surgery*
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / mortality
  • Breast Neoplasms / surgery
  • Cause of Death
  • Diagnostic Imaging
  • Disease-Free Survival
  • Female
  • Gastrointestinal Neoplasms / diagnosis
  • Gastrointestinal Neoplasms / mortality
  • Gastrointestinal Neoplasms / surgery
  • Humans
  • Karnofsky Performance Status
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / mortality
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / surgery
  • Neoplasms, Unknown Primary / diagnosis
  • Neoplasms, Unknown Primary / mortality
  • Neoplasms, Unknown Primary / surgery
  • Neurologic Examination
  • Postoperative Complications / diagnosis
  • Postoperative Complications / mortality
  • Prognosis
  • Radiosurgery*
  • Reoperation
  • Retrospective Studies
  • Sex Factors
  • Survival Rate
  • Urologic Neoplasms / diagnosis
  • Urologic Neoplasms / mortality
  • Urologic Neoplasms / surgery